arrow
M

Matthieu Allez

Université de Lille
H指数:87
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IOIBD: the International Organization for the Study of Inflammatory Bowel Disease

IOIBD:国际炎症性肠病研究组织

2026-08-020
PRE
Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID

炎症性肠病患者肠道急迫感、疾病活动度与残疾的相关性:一项来自GETAID的横断面研究

2026-08-010
PRE
Development and external validation of a predictive model for postoperative recurrence of Crohn’s disease in the biologic era

生物制剂时代克罗恩病术后复发的预测模型开发与外部验证

2026-03-270
PRE
A validated predictive biomarker for postoperative endoscopic recurrence in Crohn's disease: intestinal epithelial GPX4

克罗恩病术后内镜复发预测性生物标志物的验证:肠道上皮GPX4

2026-01-010
PRE
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study

饮食和炎症性肠病患者临床缓解:一项多中心横断面研究

2025-12-300
OAAI
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor

239例对肿瘤坏死因子拮抗剂无应答的克罗恩病患者中,ustekinumab或vedolizumab的五年疗效。

2025-12-050
PRE
Blood proteomic signatures associated with disease activity in inflammatory bowel diseases

与炎症性肠病疾病活动度相关的血液蛋白质组学特征

2025-09-010
PRE
Antigen-driven expansion of public clonal T-cell populations in inflammatory bowel diseases

炎症性肠病中抗原驱动下的公共克隆T细胞群体扩增

2025-07-015
PRE
A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial

针对黏附侵袭性大肠杆菌的抗生素与安慰剂在克罗恩病中的随机对照试验:TEOREM试验。J. Crohns Colitis 19, jjaf093

2025-07-012
PRE
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease

炎症性肠病临床试验中糖皮质激素适当管理的国际共识

2025-05-280
OAAI
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials

专家建议标准化炎症性肠病临床试验中的转录组分析

2025-04-290
PRE
Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling

Guselkumab结合CD64+ IL-23产生髓系细胞,增强了中和IL-23信号的能力

2025-03-121
OA
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study

乌帕替尼诱导治疗223例克罗恩病患者的有效性与安全性:一项GETAID多中心队列研究

2025-03-042
OAAI
The Impact of Postoperative Prophylactic Medication on Long-Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease
2025-01-240
OAAI
Trans-continental analysis of determinants of response to COVID-19 vaccination in 2268 patients with Inflammatory Bowel Disease
2025-01-220
PRE